Frazier Life Sciences Management’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-731,020
| Closed | -$17.2M | – | 55 |
|
|
2024
Q3 | $17.2M | Sell |
731,020
-101,200
| -12% | -$2.38M | 0.69% | 31 |
|
|
2024
Q2 | $13.3M | Hold |
832,220
| – | – | 0.62% | 33 |
|
|
2024
Q1 | $13.6M | Sell |
832,220
-194,200
| -19% | -$3.18M | 0.58% | 37 |
|
|
2023
Q4 | $14.2M | Sell |
1,026,420
-1,593
| -0.2% | -$22.1K | 0.76% | 35 |
|
|
2023
Q3 | $14.2M | Hold |
1,028,013
| – | – | 0.94% | 27 |
|
|
2023
Q2 | $17.5M | Sell |
1,028,013
-393,297
| -28% | -$6.7M | 1.05% | 24 |
|
|
2023
Q1 | $22.8M | Buy |
1,421,310
+93,645
| +7% | +$1.5M | 1.65% | 15 |
|
|
2022
Q4 | $10.1M | Hold |
1,327,665
| – | – | 0.63% | 31 |
|
|
2022
Q3 | $11.7M | Sell |
1,327,665
-47,400
| -3% | -$417K | 0.9% | 26 |
|
|
2022
Q2 | $9.83M | Buy |
1,375,065
+47,400
| +4% | +$339K | 0.93% | 29 |
|
|
2022
Q1 | $14.2M | Buy |
+1,327,665
| New | +$14.2M | 1.21% | 30 |
|